Approximately 1% to 3% of children under 12 months ... births and neonatal deaths. Pfizer filed for Japanese approval of Abrysvo for the prevention of RSV disease in the older adult setting ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...

RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

In the US alone, RSV infections account for approximately 177,000 hospitalisations and 14,000 deaths each year among older adults, according to Pfizer. For children younger than five years old in ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton notes.

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

“RSV symptoms are similar to a cold,” says Karen Spillett, content manager at Asthma + Lung UK. “So, it’s a runny or blocked nose, sneezing and coughing – and in babies and ...

RSV season is in full swing, according to doctors at Children’s Hospital Colorado. Denver7 spoke with a local family that is ...